ACCEPTED ABSTRACTS

Tip: Press Ctrl + F and type the abstract title to quickly find it.

ORAL PRESENTATIONS

 

MONDAY, SEPTEMBER 22
PLENARY SESSION 1 (7 X 10 MIN)
Chairpersons: M. Grigg and M. Attias)

14:35 - 16:05

  1. Defining the role of the secreted rhoptry protein toxofilin during invasion
    (M. Lodoen, C. Gerke, J. Boothroyd)
  2. The ROP5 locus contains a cluster of closely-related paralogs that mediate strain-specific differences in virulence
    (J. Boyle, M. Reese, J. Boothroyd)
  3. High throughput proteomics: experimental validation and computational analysis of gene annotations in Toxoplasma gondii
    (J.M. Dybas, C.J. Madrid-Aliste, F-Y. Che, E. Nieves, D. Rykunov, R. H. Angeletii, L.M. Weiss, K. Kim, A. Fiser)
  4. The Toxoplama gondii epigenomic map of 10 different modified histones
    (M. Gissot, E. Fajaro, A. Fisher, L. Weiss, K. Kim)
  5. The proteome of Toxoplasma gondii: implications for genome annotation and expression analysis
    (J.M. Wastling, D. Xia, S.J. Sanderson, A.R. Jones, H. Prieto, J. Yates, D. Roos, B. Brunk)
  6. Virulence shift in a sexual clade of wild Toxoplasma gondii infecting marine mammals
    (M. Miller, E. James, P. Conrad, P. Keeling, M. Grigg)
  7. Global genetic diversity and mouse-virulence of Toxoplasma gondii
    (C. Su, D. Majumdar, R. Hill, J. Dubey)
 

TUESDAY, SEPTEMBER 23
PLENARY SESSION 2 (7 X 10 MIN)
Chairpersons: R. McLeod and V. Chioccola

14.35 - 16:05

  1. Mechanism and evolution of the IRG resistance system against T. gondii in the mouse
    (J. C. Howard, S. Martens, C. Bekpen, J. Hunn, Y. Zhao, S. Khaminets, J. Li)

  2. Toxoplasma gondii secreted kinase ROP16 mediates strain-specific differences in macrophage polarization
    (Y. D. Wang, Y. C. Ong, J. Boothroyd, J. Saeij)
  3. Novel triazine inhibits Toxoplasma gondii
    (R. McLeod, E. Mui, G. Schiehser, W. Milhous, H. Hsu, C. Roberts, M. Kirisits, S. Muench, D. Rice, J.P. Dubey, J. Fowble, P. Rathod, S. Queener, S. Liu, D. Jacobus)
  4. The protective efficacy against Toxoplasma gondii infection by immunization with multi-epitope DNA vaccine in mice
    (H. Cong, Q. M. Gu, Y. Li, Q. L. Zhao, Q. L. Zhang, H. Zhou)
  5. Recurrences’ frequency and clinical related fectors in ocular toxoplasmosis in a colombian cohort
    (A. de-la-Torre, A.C. Ríos-Cadavid, C.M. Cardozo-García, J.E. Gómez-Marín)
  6. Toxoplasmosis associated neovascular lesions treated successfully with ranibizumab
    (J.D. Benevento, R.D. Jager, A.G. Noble, P. Latkany, W.F. Mieler, M. Sautter, S. Meyers, M. Mets, M.A. Grassi, P. Rabiah, K. Boyer, C. Swisher, R. McLeod)
  7. Predominance of untypable Toxoplasma gondii strains in patients with toxoplasmic retinochoroiditis in Germany
    (U. Pleyer, J. Johnsen, O. Liesenfeld, S. Metzner, N. Torun, M. Grigg)
 

WEDNESDAY, SEPTEMBER 24
PLENARY SESSION 3 (7 X 10 MIN)
Chairpersons: O. Djurkovic and W. Buffolano

14.35 - 16:05

  1. Severe acquired toxoplasmosis in immunocompetent adults requiring intensive cares management in French Guiana
    (M. Demar, D. Hommel, F. Djossou, D. Louvel, P. Néron, A.M. Bourbigot, D. Ajzenberg, M.L. Dardé, A. Hulin, B. Carme)
  2. Highly sensitive detection of Toxoplasma DNA in 100g tissue samples by magnetic capture and PCR
    (M. Opsteegh, A. Titilincu, M. Langelaar, H. Sprong, J. Roelfsema, S. Brandes, J. Giessen)
  3. Development of a Toxoplasma-free meat label
    (A. Kijlstra, E. Jongert)
  4. The marine cycle of Toxoplasma gondii: investigation of seals in the Arctic
    (A. Simon, M. Bigras-Poulin, R. A. Guy, M. Simard, B. J. Ward, B. Levesque, J-F Proulx, N. H. Ogden)
  5. The incidence of congenital toxoplasmosis and the vertical transmission rate in children born in a public hospital
    (I. R. S. Varella, B. R. Santos, I. C. T. Canti, L.C. Argondizzo, M. B. Wagner)
  6. The epidemiology of toxoplasmosis in China
    (X-G. Chen)
  7. The introduction of monitoring and control of gestational/congenital toxoplasmosis in Brazil: advancement and challenges
    (R. M. Souza-Alves, I. T. Navarro, M. Garcia, A. Reis, L.C. Melo, J. R. Pio-Marins)

 

SPECIAL POSTER PRESENTATIONS

MONDAY, SEPTEMBER 22
FORUM 1: Genetics and pathogenesis
Moderator: J. Boothroyd

16.30 - 17:30

4 x 5 min:
  1. Role of glycosylphosphatidylinositols in the pathogenicity of apicomplexan parasites
    (N. Azzouz, F. Kamena, B. Lepenies, M. Treeck, T. W. Gilberger, P. H. Seeberger)
  2. Interaction and cystogenesis of Toxoplasma gondii within the skeletal muscle cells in vitro
    (E.V. Guimarães, L. Carvalho, H.S. Barbosa)
  3. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America
    (F. Peyron, S. Morisset, J. Lobry, J. Garweg, E. Petersen, V. Meroni, J. E. Gomez-Marin, A. de-la-Torre, B. Carme, J. F. Garin, M-F. Cesbron)
  4. Genetic characterization of Toxoplasma gondii isolates from China
    (P. Zhou, H. Zhang, R.Q. Lin, H.Q. Song, C. Su, X.Q. Zhu)
Open debate: Pannellists: D. Ferguson, A. Barragan

 

TUESDAY, SEPTEMBER 23
FORUM 2: Critical points in vaccine development
Introducing expert conference and moderator: E. Petersen / E. Jongert
16.30 - 17:30
2 x 5 min:

  1. A GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in mice and pigs
    (E. Jongert, V. Melkebeek, S. De Craeye, D. Verhelst, E. Cox)
  2. Ribosomal protein S13 conditional knockout parasite protects mice from toxoplasmosis
    (R. McLeod, S. Hutson, E. Mui, B. Rohrman, W. Witola, N. von Poppel, R. Schaap)

Topics:

 

POSTER SESSIONS

 

MONDAY, SEPTEMBER 22
Session 1 (90 minutes)

17:30 - 19:00

Clinical Management:
1. Serological detection of the chronic Toxoplasma gondii infection with the recombinant bradyzoite stage-specific antigen BAG1
2. Acute toxoplasmosis and pregnancy: study of frequency, vertical transmission rate and the relationship between the maternal-fetal diagnostic tests
3. Serum levels of dehydroepiandrosterone-sulphate (DHEA-S)
4. Clinical characteristics in a Colombian cohort of ocular toxoplasmosis
5. Ophthalmologic outcomes of 113 congenital toxoplasmosis
6. Ocular manifestations of congenital toxoplasmosis in southern Brazil
7. Ocular toxoplasmosis in the extreme south of Brazil
8. Persistence of specific IgA antibodies after Toxoplasma infection
9. Serological monitoring of a Toxoplasma infection after hematopoietic stem cell transplantation
10. Performance evaluation of the new automated VIDIA Toxo IgG and status assessment of results within the grey zone
11. Multifocal acquired toxoplasmic retinochoroiditis
12. Evaluation of fully automated assays for the detection of anti-Toxoplasma IgM and IgG antibodies on the Elecsys immunoassay system
13. IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women
14. Performance characteristics of the new architect Toxo IgM assay
15. Quantitative and qualitative comparison of the new architect Toxo IgG assay to 4 commercially available Toxo IgG assays
16. Toxoplasmosis acquired during pregnancy in a reference outpatient unit. Rio de Janeiro, Brazil
17. Acute acquired toxoplasmosis: clinical-laboratorial aspects and ophthalmologic evaluation in a cohort of immunocompetent patients.
18. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: biological results (DNA detection and serological techniques) in 70 patients
19. Serologic evidence of Toxoplasma gondii acute infection in pregnant women of Cascavel, Paraná, Brazil
20. Comparison between PCR and nested PCR using the B1 gene for the diagnosis of toxoplasmic encephalitis in immunocompromised patients
21. An approach to the knowledge of ocular and pregnancy toxoplasmosis in Cuba
22. Congenital toxoplasmosis. Relevance of antibody response to SAG1 for vertical transmission or perinatal morbidity in a semirural community of Mexico
23. Prevalence of gestational/congenital toxoplasmosis in a public health service from a school hospital, northwestern region of São Paulo state, Brazil
24. Use of metric determination of specific anti-T. gondii IgG in diagnostic serology
25. Molecular diagnosis of cerebral toxoplasmosis: comparison of markers for use in PCR for Toxoplasma gondii determination
26. Importance of confirmation of serological diagnosis with reactivity to IgM anti-Toxoplasma gondii in pregnant women
27. Toxoplasma gondii infection in pregnancy: where tests defy diagnosis
28. Toxoplasma gondii infection in dogs: antibodies detection by indirect hemagglutination and indirect immunofluorescence
29. Toxoplasma gondii excreted-secreted antigen: use for serum reactivity in cerebral toxoplasmosis diagnosis in HIV-infected patients
30. Recombinant surface antigen 2 (SAG2A) of Toxoplasma gondii as a potential diagnostic marker for human acute toxoplasmosis
31. Quality of life assessment in patients with ocular toxoplasmosis
32. A panel of molecular markers to evaluate Toxoplasma gondii in immunocompetent patients with acute or quiescent disease
33. Maternal-fetal Toxoplasma gondii infection: four years of pre- and post-natal evaluation
34. Outcomes of treatment of congenital toxoplasmosis (CT), 1981-2004, national collaborative Chicago-based congenital toxoplasmosis study
35. Real-time quantitative PCR for pulmonary and disseminated toxoplasmosis diagnosis
36. Experimental infection of different genotypes Toxoplasma gondii tissue cysts on pregnant queens
37. Fatal case of congenital toxoplasmosis after transmission from an HIV-infected mother with chronic T. gondii infection
38. Direct genotyping of Toxoplasma gondii strains from aqueous humor shows no association between genotype and occurrence of ocular toxoplasmosis
Public Health:
1. Serological inquiry and isolation of Toxoplasma gondii of sheeps from a Brazilian slaughterhouse
2. Seroprevalence and risk factors for canine toxoplasmosis in the cities of Lages and Balneário Camboriú, Santa Catarina state, Brazil
3. Serological screening for toxoplasmosis of pregnant women in Slovenia in the period 2000-2007
4. Occurrence of Toxoplasma gondii infection in wild boars (Sus scrofa) raised in Brazil
5. Toxoplasma and toxoplasmosis in China
6. Toxoplasma gondii in the UK: seroprevalence in the human population
7. Toxoplasmosis seroprevalence of the Rio Grande do Sul (RS), Brazil
8. Frequency of antibodies anti-Toxoplasma gondii in white-lipped peccaries (Tayassu pecar) wild or captivity, Brazil
9. First infection with Toxoplasma gondii during pregnancy
10. Enhanced surveillance for Toxoplasma infection in England & Wales
11. Prevalence and estimated incidence of Toxoplasma gondii infection in pregnant women in Argentina
12. Parasitological and histopathological analysis of biological samples from pregnant women with clinical and serological indication of acute toxoplasmosis
13. Serologic evaluation of toxoplasmosis in matrimonial women in Babol, Iran
14. Estimation of the dose-infection relationship for Toxoplasma gondii from experimental animal data
15. Knowledge of toxoplasmosis and preventive behavior reported by women with suspected acute toxoplasmosis in pregnancy
16. Toxoplasmosis in pregnant women attended at Hospital Universitário Regional de Maringá (HURM), Paraná, Brazil
17. Newborn screening for congenital toxoplasmosis in Neiva, Colombia
18. Surveillance system of congenital toxoplasmosis in France
19. Prevalence and risk factors for anti-Toxoplasma gondii antibodies in goats of Rio Grande do Norte state, Brazil
20. Antibodies anti-Toxoplasma in two populations of Maranhão state, Brazil: a pilot study
21. Seroepidemiology of Toxoplasma gondii in students at Faculdades Luiz Meneghel, Bandeirantes, PR, Brazil
22. Toxoplasmosis infection in wild animals
23. Seropositivity of anti-Toxoplasma gondii antibodies in pregnant women of Cambé, Paraná, Brazil: preliminary results
24. Factors associated with the seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil
25. Introduction of a surveillance program on health of congenital toxoplasmosis: an experience of Londrina, PR
26. Occurrence of infection by Toxoplasma gondii in non human primates from Paraná, Brazil, and comparison of serological techniques
27. Neonatal screening for congenital toxoplasmosis: a tool for prevention
28. Perinatal diagnosis, evolution and results of pregnant women with IgM anti-Toxoplasma gondii, attended at the university hospital, Paraná, Brazil
29. Seroprevalence of anti-T. gondii antibodies in pregnant women detected on dried blood spot samples
30. Jojutla, Morelos: a highly endemic region for Toxoplasma gondii in México. Seroprevalence and risk factors in pregnant women with high and low risk obstetric history
31. Performance of prenatal screening against congenital toxoplasmosis in southern Italy
32. Lactational transmission of Toxoplasma gondii in experimentally infected Wistar female rats
33. Eco-epidemiological, serological and clinical study of infection with Toxoplasma gondii in a rural region (Rio de Janeiro, Brazil 2004-2006)
34. Prevalence and risk factors associated with Toxoplasma gondii infection in sheep in the state of Alagoas, Brazil
35. Antibodies to Toxoplasma gondii in domestic cats from Brazil
36. First serologic evidence for Toxoplasma gondii in cats and dogs from Fernando de Noronha archipelago, Pernambuco, Brazil
37. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women in a public hospital in south Brazil
38. Epidemiologic profile of outbreak of toxoplasmosis in Brazil, 2002-2007
39. Neurological and ophthalmological evaluation of children with congenital toxoplasmosis referred to the toxoplasmosis reference clinic in Campos, RJ
40. Evaluation of cases referred to the reference outpatient clinic for toxoplasmosis in Campos, from 1998 until 2008
41. Maternal symptoms during pregnancy as risk factors for congenital toxoplasmosis in a highly endemic area in Rio de Janeiro state, Brazil
42. Disease burden of Toxoplasma in DALYs

TUESDAY, SEPTEMBER 23
Session 2 (90 minutes)

17:30 - 19:00
Immunology:
1. P30 peptides recognition pattern in human toxoplasmosis
2. Toxoplasma gondii congenital infection: specific antibody and cytokine profiles in mother/newborn pairs
3. Immune response and oral protection of C57bl/6j and BALB/c mice immunized with irradiated tachyzoites of Toxoplasma gondii
4. IgG subclasses and cytokines expression in C57BL/6J and BALB/c mice immunized with irradiated tachyzoites of Toxoplasma gondii
5. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice
6. Performance of Elecsys Toxo IgG and IgM immunoassays
7. Psychosis may be associated with toxoplasmosis
8. Recombinant viral vectors encoding SAG proteins from Toxoplasma gondii induce protective immunity associated with strong antigen-specific CD8+ T cell response
9. Protective immunity against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart
10. The GRA1-GRA7 cocktail DNA vaccine: protective cellular immune responses from mice to pigs (Forum 2)
11. Experimental double infections of mice with genetic distinct strains of Toxoplasma gondii
12. Jacalin effect in immunization against Toxoplasma gondii infection
13. Toxoplasmosis in pregnancy in Curitiba, Paraná state, southern Brazil
14. Mast cells and the susceptibility to Toxoplasma gondii infection by BALB/c and C57BL/6 mice
15. Evaluation of parasite antigens in ELISA for the detection of Toxoplasma infection in pigs
16. Immunization with tachyzoite excreted-secreted proteins reduces Toxoplasma gondii infection in susceptible as/n mice
17. Toxoplasma gondii exposes phosphatidylserine as an evasion mechanism
18. Role of MIF in protection of trophoblast cell (BeWo and placental explants of third trimester pregnancy) against Toxoplasma gondii infection
19. Apoptosis analysis in BeWo trophoblast cell infected with Toxoplasma gondii RH and ME49 strains
20. Cytokine response and histological alterations in ocular toxoplasmosis
21. Inactivation of CD4+CD25+ Treg cells increases intestinal T. gondii burden and augments pro-inflammatory cytokine levels
22. Characterization of cytokine cDNA sequences in the animal model Calomys Callosus
23. Comparison of chemiluminescence technique and indirect immunofluorescence antibody test in the detection of human IgG antibodies against Toxoplasma gondii
24. Toxoplasma gondii infection modulated by extracellular ATP
25. Longitudinal serologic evaluation in toxoplasmosis: kinetics of IgG, IgM and IgA reactivity in patients following primary infection
26. Ribosomal protein S13 conditional knockout parasite protects mice from toxoplasmosis (Forum 2)
27. Partial evaluation of protection against congenital transmission in mice immunized by nasal route with crude rhoptry proteins of Toxoplasma gondii
28. Immunized mice with irradiated Toxoplasma gondii induce partial protection against lethal doses with ME49 cysts and serum prevent cellular invasion
29. Isolation and identification of immunogenic Toxoplasma gondii antigens expressed by a protective genomic library vaccine
30. Chemokine production profile in patients with toxoplasmic retinochoroiditis in the city of Campos dos Goytacazes
31. Investigation of immunogenetic and environmental risk factors predominant in the development of toxoplasmic retinochoroiditis
32. Toxoplasma gondii experimental infection in genetically selected mice for extreme oral tolerance phenotypes
Basic biology:
1. Role of glycosylphosphatidylinositols in the pathogenicity of apicomplexan parasites (Forum 1)
2. Infection with virulent strain of Toxoplasma gondii alters circadian clock gene expression in cortical and sub-cortical structures of mouse brain
3. Mechanisms of sulfonamide resistance in three strains in Toxoplasma gondii
4. Expression analysis of P-glycoprotein and MRP homologues in the three major genotypes of Toxoplasma gondii
5. Study of the regulation of conoid extrusion in Toxoplasma gondii tachyzoites
6. Lipid metabolism alterations in experimental murine toxoplasmosis
7. Anti-Toxoplasma gondii effects of new thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles
8. Ultrastructural aspects of host cell invasion by Toxoplasma gondii
9. Fatty acid biosynthesis inhibitors thiolactomycins as potential anti-Toxoplasma gondii agents
10. New aspects of the ultrastructure of Toxoplasma gondii cysts
11. Experimental reinfection of BALB/c mice with different recombinant type I/III strains of Toxoplasma gondii: involvement of IFN-g and IL-10
12. In vitro evaluation of Artemisia annua extract on Toxoplasma gondii infection in human fibroblasts
13. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation
14. Systematic analysis of vesicle trafficking in apicomplexan parasites
15. Studies on calcium ionophore induced egress of Toxoplasma gondii in LLC-MK2 cells
16. Transient transfection of the tandem yellow fluorescent protein
17. Interaction and cystogenesis of Toxoplasma gondii within the skeletal muscle cells in vitro (Forum 1)
18. Induced x spontaneous stage differentiation of Toxoplasma gondii: is the host cell type critical for Toxoplasma stage conversion?
19. Evaluation of the infectivity of Toxoplasma gondii in primary cultures of feline intestinal epithelial cells
20. Isolation and characterization of Toxoplasma gondii from newborns with congenital toxoplasmosis identified by the neonatal screening program in Minas Gerais, Brazil
21. Spatiofunctional compartmentalization of the T. gondii mitochondrion
22. Selection of epitopes of ROP18 for possible typification of Toxoplasma gondii
23. Genotyping of Toxoplasma gondii isolated from chickens from Mato Grosso do Sul state, Brazil: preliminary results
24. Lipid bodies of mouse peritoneal macrophages: microbicidal action, and association with Toxoplasma gondii
25. IL-6 is required for the generation of T follicular helper cells during Toxoplasma gondii infection
Genetics:
1. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America (Forum 1)
2. Polymorphisms in gene encoding IFN-gama and susceptibility to ocular toxoplasmosis
3. Genetic characterization of Toxoplasma gondii isolates from China (Forum 1)
4. Molecular characterization of Toxoplasma gondii isolated from patients with clinical and laboratory diagnostic of congenital toxoplasmosis
5. Population biology of Toxoplasma gondii: what’s out and where did they come from
6. Towards the mechanism by which the Toxo1 locus controls the outcome of the infection in rat
7. Toxoplasmosis, RH blood group and reaction times: possible mechanism of preservation of RHD polymorphism in human populations
8. Genotyping of strains from Brazilian pregnant and AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers
9. Genotyping characterization of Toxoplasma gondii strains isolated from pregnant women
10. Population structure of Toxoplasma gondii in Gabon
11. First genotyping of Toxoplasma gondii isolates in free-range chickens from northeastern states of Brazil revealed diverse and atypical genotypes
12. Genotyping of Toxoplasma gondii isolates in sheep and goats from São Paulo state, Brazil
13. Isolation and molecular characterization of Toxoplasma gondii in urban rodents from São Paulo state, Brazil
14. Drug-inhibition of HDAC activity: epigenetic control of cell cycle and differentiation in apicomplexan parasites
15. Genotyping of Toxoplasma gondii isolates in free-range chickens from the middle western Mato Grosso do Sul state, Pantanal, Brazil
16. Extensive genetic and biologic characterization of eight Toxoplasma gondii strains from Uganda

WEDNESDAY, SEPTEMBER 24
Session 3 (50 minutes)

13:40 - 14:30
Environment:
1. Seroepidemiological survey of Toxoplasma gondii infection in Gansu and Qinghai province, China
2. Frequency and risk factors for toxoplasmosis in ovines of various regions of the state of Colima, Mexico
3. A serological survey of Toxoplasma gondii in cattle: different analysis, different results
4. Study of toxoplasmosis in a rural community of Eldorado, MS, Brazil
5. Antibody detection and isolation of Toxoplasma gondii from chickens from a rural community from Mato Grosso do Sul, Brazil
6. Seroprevalence of Toxoplasma gondii in organic chicken (Gallus domesticus) from a rural property in the state of Rio de Janeiro, Brazil
7. Prevalence of Toxoplasma gondii infection in domestic cats from Romania
8. Seroprevalence of Toxoplasma gondii infection in small ruminants from Romania
9. The usefulness of recombinant antigens derived from Toxoplasma gondii in a turkey-specific ELISA
10. Seroprevalence of Toxoplasma gondii in free range chickens sold for human consumption in Maricá, Rio de Janeiro, Brazil
11. Toxoplasma gondii in the UK: seroprevalence in terrestrial and marine mammals
12. Toxoplasma gondii in free-range pigeons captured in Sorocaba, SP: preliminary results
13. Toxoplasmosis in swine at the slaughter line of the Belgrade city abattoirs
14. Serological survey to Toxoplasma gondii in cats from Paraná and Mato Grosso do Sul
15. Serological inquiry to Toxoplasma gondii in swines submitted to rustic conditions breeding
16. Molecular characteristics of Toxoplasma gondii isolates from wildlife in France
17. Survey of the seroprevalence of Toxoplasma gondii in ovine meat in France
18. Rodents and shrews and their role in the transmission of Toxoplasma gondii to pigs
19. Dynamics of the natural cycle of Toxoplasma gondii in contrasted environments: a modeling approach
20. Toxoplasmosis in urban rodents in the Belgrade area
21. Toxoplasma gondii in urban rats and seroprevalence in contacting dogs, Londrina city, Brazil
22. Toxoplasma in free-range chickens from rural areas of Espírito Santo: high prevalence of virulent strains
23. Occurrence of antibodies to Toxoplasma gondii in ostrich breeding farms in Rio de Janeiro, Brazil
24. Search of Toxoplasma gondii DNA in shellfish from Adriatic sea, Italy
25. Occurrence of anti-Toxoplasma gondii antibodies in sheep from northwest region of São Paulo state, Brazil
26. Prevalence of antibodies against Toxoplasma gondii in domestic cats from Mexico city and risk factors associated
27. Detection of antibodies to Toxoplasma gondii and Neospora caninum in Brazilian wild captive felids
28. Monitoring of Toxoplasma gondii prevalence in commercial meat by polymerase chain reaction in Rio de Janeiro state
29. Monitoring of Toxoplasma gondii prevalence in vegetables and fruits samples by polymerase chain reaction in Rio de Janeiro state
30. Surface properties of Toxoplasma gondii oocysts and surrogate microspheres
31. Prevalence of antibodies against Toxoplasma gondii in dogs in Foz do Iguaçú city, Paraná, Brazil
32. Prevalence of antibodies against Toxoplasma gondii in sheep from the south of Rio Grande do Sul state, Brazil
33. Toxoplasma gondii infection via semen in sheeps
34. Reproductive failure in the initial phase of gestation in sheeps experimentally inoculated via semen with Toxoplasma gondii
35. Investigation of anti-Toxoplasma gondii antibodies, by several serological assays, in horses from Caraguatatuba, and in dogs from Caraguatatuba, Itupeva, Bauru, Mogi das Cruzes and Sorocaba, São Paulo state, Brazil
36. Toxoplasmosis’ serology in ovines and caprines from breeders of seaside towns of the state of Rio de Janeiro, Brazil
37. First clinical case report of acute toxoplasmosis in felines in the state of Espírito Santo, Brazil
Others:
1. Atrophy of the intestinal wall of Gallus gallus infected with tissue cysts of Toxoplasma gondii
2. Occurrence of anti-Toxoplasma gondii antibodies in wild animals from the city of São Paulo
3. Neutralization assay to confirm low-positive results in highly sensitive anti-Toxoplasma IgG immunoassays
4. Morphometric analysis of the swine intestinal mucosa after a 60-day infection caused by a genotype III strain of Toxoplasma gondii
5. The usefulness of PCR-RFLP B1 for diagnosis and direct genotyping of Toxoplasma gondii in HIV patients with toxoplasmic encephalitis
6. Analysis of the neutral glycoconjugate secretion in the mucosa of swine jejunum infected with a genotype III Toxoplasma gondii strain
7. Acid glycoconjugates in the mucosa of swine jejunum infected with genotype III Toxoplasma gondii strain
8. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis
9. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis
10. Optimization of the Toxoplasma gondii antigen in vivo production in high concentration
11. Calomys callosus infect with Toxoplasma gondii (ME-49 strain) is unable to transmit congenital toxoplasmosis, even when reinfected
12. Evaluation of VIDIA Toxo IgG and Toxo IgM for the routine serodiagnosis of toxoplasmosis compared to VIDAS reagents
13. Quantitative analysis of NADH-diaphorase positive neurons of the jejunum of rats subjected to acute infection caused by Toxoplasma gondii oocysts
14. Human toxoplasmosis: an outbreak in Monte Dourado district, Pará state, Brazil
15. Detections of genomic DNA and Immunoglobin G (IgG) antibodies against Toxoplasma gondii and Neospora caninum in sera from African and Danish patients
16. Effect of dietary mycotoxin in mice with chronical toxoplasmosis
17. Assessing the accuracy of screening tests of congenital toxoplasmosis with emphasis on T. gondii DNA detection using polymerase chain reaction-nested

Print Print it